Rett Syndrome Drug Studied at Vanderbilt Approved for Patients
July 08, 2023
July 08, 2023
NASHVILLE, Tennessee, July 8 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
The first drug to treat the symptoms of Rett syndrome was recently approved, following a Nature Medicine study publishing results from the pivotal phase 3 LAVENDER study led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety of trofinetide.
Positive findings from the study were integral to the Food and Drug Administration's (FD . . .
The first drug to treat the symptoms of Rett syndrome was recently approved, following a Nature Medicine study publishing results from the pivotal phase 3 LAVENDER study led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety of trofinetide.
Positive findings from the study were integral to the Food and Drug Administration's (FD . . .